“OPTIMIZING NON-INVASIVE DIAGNOSIS OF LIVER FIBROSIS SEVERITY USING PRO-C3/ADAPT INDEX IN PATIENTS WITH MASLD”, YHCĐ, vol. 67, no. CD14, Sept. 2026, doi: 10.52163/yhc.v67iCD14.6447.